Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 7, 2025
Netstock's Tariff Impact Report Provides Proactive Strategies for SMB Resilience
GlobeNewswire
·
May 7, 2025
BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Netstock, a leader in supply chain planning solutions for small and medium-sized businesses (SMBs), today announced the release of its Tariff Impact Report 2025: 5 Proactive Strategies for SMBs. Developed in …
Pramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative Pipeline
GlobeNewswire
·
May 7, 2025
VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Pramana Pharmaceuticals, a late-stage preclinical biopharmaceutical company developing a transformative small molecule platform targeting the intersection of metabolism, immunity, and …
TransGlobal Assets Inc. (OTC: TMSH) Prioritizes Development and Pre-Market Launch of Flagship Social App “DateGuard”
GlobeNewswire
·
May 7, 2025
TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- TransGlobal Assets Inc. (OTC: TMSH), a forward-focused technology incubator, is pleased to announce that it has officially prioritized the development and pre-market rollout of DateGuard, its flagship social and …
Impact Analytics Secures Series D Funding to Accelerate Global Expansion and Lead in Agentic AI
GlobeNewswire
·
May 7, 2025
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Impact Analytics™, the leader in AI-native innovation and the only provider of an end-to-end platform for pricing, merchandising, and supply chain, today announced a new growth investment from Blue Cloud Ventures, …
Alkeus Pharmaceuticals Presents Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
GlobeNewswire
·
May 7, 2025
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced additional data from its Phase 2 clinical study ( …
VERSES Issues Inaugural Monthly Newsletter May 2025
GlobeNewswire
·
May 7, 2025
VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”) is pleased to announce the launch of its inaugural monthly newsletter. FROM THE CEO Welcome to the inaugural issue of …
Gogo confirms PMA for Gogo Galileo FDX, facilitating STC generation for super-midsize and larger aircraft.
GlobeNewswire
·
May 7, 2025
Boulder, CO., May 07, 2025 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) has received PMA (Parts Manufacturer Approval) from the Federal Aviation Administration (FAA) for its Gogo Galileo FDX antenna. With PMA confirmed, the global Gogo dealer network is pushing …
Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop
GlobeNewswire
·
May 7, 2025
ALAMEDA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, …
Jamf Announces Upcoming Conference Participation
GlobeNewswire
·
May 7, 2025
MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today that members of its management team will present at the following investor conference: J.P. Morgan 53rd Annual Global …
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
GlobeNewswire
·
May 7, 2025
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the Bank of America Securities 2025 …
Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC
GlobeNewswire
·
May 7, 2025
MORRISTOWN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and …
Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
GlobeNewswire
·
May 7, 2025
Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patents Patent estate covering atrioventricular interval modulation (“AVIM”) therapy now …
NextNav to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 7, 2025
RESTON, Va., May 07, 2025 (GLOBE NEWSWIRE) -- NextNav Inc. (the "Company" or “NextNav”) [NASDAQ: NN], a leader in next-generation positioning, navigation, and timing (“PNT”) and 3D geolocation, today announced that Chief Financial Officer, Chris Gates, …
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
GlobeNewswire
·
May 7, 2025
- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025 (GLOBE …
Illinois Tech to Open Mumbai Campus: First U.S. University Approved to Establish a Degree-Granting Campus in India
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Illinois Institute of Technology (Illinois Tech), Chicago’s only tech-focused university, today announced it has received formal approval from India’s University Grants Commission (UGC) to open a new campus in …
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
GlobeNewswire
·
May 7, 2025
MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity …
Testsigma announces autonomous testing capabilities - ushering in the era of agentic AI
GlobeNewswire
·
May 7, 2025
San Francisco, May 07, 2025 (GLOBE NEWSWIRE) -- Testsigma, the leading cloud-based testing platform, today introduced autonomous testing capabilities to its automation suite — powered by AI coworkers that collaborate with QA teams to simplify testing, …
NKGen Biotech to Present Troculeucel Clinical and Biomarker Results at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire
·
May 7, 2025
SANTA ANA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 7, 2025
PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S. Krishnan, …
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
GlobeNewswire
·
May 7, 2025
RADNOR, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …